Bulletin de Périodique
International Journal of Drug Policy , Vol.119 - September 2023
Paru le :
01/09/2023
Année
2023
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- "We were all looking for the magic pill": A qualitative study of patient experiences using gabapentinoids for chronic pain. McNeilage A.G., Ashton-James C.E., Scholz B., art. 104112.
- Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis. Reddon H., Lake S., Socias M.E., Hayashi K., DeBeck K., Walsh Z., et al., art. 104113.
- Alignment in local approaches to alcohol and cannabis control policy: A case study of California cities and counties. Matthay E.C., Mousli L., Apollonio D.E., Schmidt L.A., art. 104114.
- Influencing the global governance of alcohol: Alcohol industry views in submissions to the WHO consultation for the Alcohol Action Plan 2022-2030. O'Brien P., Dwyer R., Gleeson D., Cook M., Room R., art. 104115.
- "There must be something good": Fair balance and ad appeal of marijuana brands' website. Rhee S., Jung W., art. 104116.
- Socioeconomic marginalization and risk of overdose in a community-recruited cohort of people who use drugs: A longitudinal analysis. Mitra S., Choi J., van Draanen J., Kerr T., Gilbert M., Hayashi K., et al., art. 104117.
- Virtual overdose monitoring services and overdose prevention technologies: Opportunities, limitations, and future directions. Rioux W., Marshall T., Ghosh S.M., art. 104121.
- Residence in urban or rural counties in relation to opioid overdose mortality among Kentucky hospitalizations before and during the COVID-19 pandemic. Blair L.K., Howard J., Peiper N.C., Little B.B., Taylor K.C., Baumgartner R., et al., art. 104122.
- Is non-medical use normal? Normalisation, medicalisation and pharmaceutical consumption. Dertadian G.C., art. 104123.
- Institutional violence from police militarization and drug cartel wars as a 'Big Event' and its influence on drug use harms and HIV risk in people who inject drugs on the U.S.-Mexico border. Lechuga J., Ramos R., Dickson-Gomez J., Beachy S., Perez G., Nevola O., et al., art. 104125.
- Decriminalization thresholds for drug possession: A multi-criteria policy analysis framework. McAdam E., Small W., Mullins G., Graham B., Greer A., Winder N., et al., art. 104126.
- Perspectives and recommendations of opioid overdose survivors experiencing unsheltered homelessness on housing, overdose, and substance use treatment in Boston, MA. Paradise R.K., Desmarais J., O'Malley S.E., Hoyos-Cespedes A., Nurani A., Walley A.Y., et al., art. 104127.
- "They sent it away for testing and it was all bunk": Exploring perspectives on drug checking among steroid consumers in Queensland, Australia. Piatkowski T., Puljevic C., Francis C., Ferris J., Dunn M., art. 104139.
- The impact of Medicaid expansion on mental health and substance use related inpatient visits. Jayawardhana J., art. 104140.
- Typology of laws restricting access to methadone treatment in the United States: A latent class analysis. Conway A., Krawczyk N., McGaffey F., Doyle S., Baaklini V., Marshall A.D., et al., art. 104141.
- Optimism and eternal vigilance: Gathering disease, responsible subjects and the hope of elimination in the new hepatitis C treatment era. Nourse G., Farrugia A., Fraser S., Moore D., Treloar C., art. 104142.
- Medical cannabis laws lower individual market health insurance premiums. Cook A.C., Sirmans E.T., Stype A., art. 104143.
- The impact of border crossing and imprisonment on injection practices and risk of HIV and hepatitis C infection among men who inject drugs in Nepal. Zaccheo S.K., Marrone G., Pandey L.R., Deuba K., art. 104145.
- Changing dynamics of drug overdoses in the United Kingdom: An attempt to replicate the Jalal et al. findings of steady exponential growth. Aziani A., Caulkins J.P., art. 104146.
- Can alcohol policy prevent harms to women and children from men's alcohol consumption? An overview of existing literature and suggested ways forward. Karriker-Jaffe K.J., Blackburn N., Graham K., Walker M.J., Room R., Wilson I.M., et al., art. 104148.
- "I don't want to introduce it into new places in my life": The marketing and consumption of no and low alcohol drinks. Nicholls E., art. 104149.
- Phentermine involvement in fatal drug overdoses in Tennessee, 2019-2022. Hall K.F., Korona-Bailey J., Mukhopadhyay S., art. 104151.
- Disentangling opioids-related overdose syndemics: a scoping review. Lang J., Mendenhall E., Koon A.D., art. 104152.
- Changes in arrests following decriminalization of low-level drug possession in Oregon and Washington. Davis C.S., Joshi S., Rivera B.D., Cerda M., art. 104155.
- Cannabis industry campaign expenditures in Colorado, 2005-2021. Rotering T., Bialous S., Apollonio D., art. 104156.
- "We were all looking for the magic pill": A qualitative study of patient experiences using gabapentinoids for chronic pain. McNeilage A.G., Ashton-James C.E., Scholz B., art. 104112.
- Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis. Reddon H., Lake S., Socias M.E., Hayashi K., DeBeck K., Walsh Z., et al., art. 104113.
- Alignment in local approaches to alcohol and cannabis control policy: A case study of California cities and counties. Matthay E.C., Mousli L., Apollonio D.E., Schmidt L.A., art. 104114.
- Influencing the global governance of alcohol: Alcohol industry views in submissions to the WHO consultation for the Alcohol Action Plan 2022-2030. O'Brien P., Dwyer R., Gleeson D., Cook M., Room R., art. 104115.
- "There must be something good": Fair balance and ad appeal of marijuana brands' website. Rhee S., Jung W., art. 104116.
- Socioeconomic marginalization and risk of overdose in a community-recruited cohort of people who use drugs: A longitudinal analysis. Mitra S., Choi J., van Draanen J., Kerr T., Gilbert M., Hayashi K., et al., art. 104117.
- Virtual overdose monitoring services and overdose prevention technologies: Opportunities, limitations, and future directions. Rioux W., Marshall T., Ghosh S.M., art. 104121.
- Residence in urban or rural counties in relation to opioid overdose mortality among Kentucky hospitalizations before and during the COVID-19 pandemic. Blair L.K., Howard J., Peiper N.C., Little B.B., Taylor K.C., Baumgartner R., et al., art. 104122.
- Is non-medical use normal? Normalisation, medicalisation and pharmaceutical consumption. Dertadian G.C., art. 104123.
- Institutional violence from police militarization and drug cartel wars as a 'Big Event' and its influence on drug use harms and HIV risk in people who inject drugs on the U.S.-Mexico border. Lechuga J., Ramos R., Dickson-Gomez J., Beachy S., Perez G., Nevola O., et al., art. 104125.
- Decriminalization thresholds for drug possession: A multi-criteria policy analysis framework. McAdam E., Small W., Mullins G., Graham B., Greer A., Winder N., et al., art. 104126.
- Perspectives and recommendations of opioid overdose survivors experiencing unsheltered homelessness on housing, overdose, and substance use treatment in Boston, MA. Paradise R.K., Desmarais J., O'Malley S.E., Hoyos-Cespedes A., Nurani A., Walley A.Y., et al., art. 104127.
- "They sent it away for testing and it was all bunk": Exploring perspectives on drug checking among steroid consumers in Queensland, Australia. Piatkowski T., Puljevic C., Francis C., Ferris J., Dunn M., art. 104139.
- The impact of Medicaid expansion on mental health and substance use related inpatient visits. Jayawardhana J., art. 104140.
- Typology of laws restricting access to methadone treatment in the United States: A latent class analysis. Conway A., Krawczyk N., McGaffey F., Doyle S., Baaklini V., Marshall A.D., et al., art. 104141.
- Optimism and eternal vigilance: Gathering disease, responsible subjects and the hope of elimination in the new hepatitis C treatment era. Nourse G., Farrugia A., Fraser S., Moore D., Treloar C., art. 104142.
- Medical cannabis laws lower individual market health insurance premiums. Cook A.C., Sirmans E.T., Stype A., art. 104143.
- The impact of border crossing and imprisonment on injection practices and risk of HIV and hepatitis C infection among men who inject drugs in Nepal. Zaccheo S.K., Marrone G., Pandey L.R., Deuba K., art. 104145.
- Changing dynamics of drug overdoses in the United Kingdom: An attempt to replicate the Jalal et al. findings of steady exponential growth. Aziani A., Caulkins J.P., art. 104146.
- Can alcohol policy prevent harms to women and children from men's alcohol consumption? An overview of existing literature and suggested ways forward. Karriker-Jaffe K.J., Blackburn N., Graham K., Walker M.J., Room R., Wilson I.M., et al., art. 104148.
- "I don't want to introduce it into new places in my life": The marketing and consumption of no and low alcohol drinks. Nicholls E., art. 104149.
- Phentermine involvement in fatal drug overdoses in Tennessee, 2019-2022. Hall K.F., Korona-Bailey J., Mukhopadhyay S., art. 104151.
- Disentangling opioids-related overdose syndemics: a scoping review. Lang J., Mendenhall E., Koon A.D., art. 104152.
- Changes in arrests following decriminalization of low-level drug possession in Oregon and Washington. Davis C.S., Joshi S., Rivera B.D., Cerda M., art. 104155.
- Cannabis industry campaign expenditures in Colorado, 2005-2021. Rotering T., Bialous S., Apollonio D., art. 104156.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
G. C. DERTADIAN
|
2023
Dans International Journal of Drug Policy (Vol.119, September 2023) Article : Périodique
Dans International Journal of Drug Policy (Vol.119, September 2023) Article : Périodique
The theory of the normalisation of youth drug use in advanced capitalist societies has had an enduring legacy in contemporary drug scholarship. While the literature on the normalisation of 'illicit' drugs is well developed, less has been written[...]
K. J. KARRIKER-JAFFE ;
N. BLACKBURN ;
K. GRAHAM ;
M. J. WALKER ;
R. ROOM ;
I. M. WILSON ;
O. WALEEWONG ;
G. GILCHRIST ;
L. RAMSOOMAR ;
A. M. LASLETT
|
2023
Dans International Journal of Drug Policy (Vol.119, September 2023) Article : Périodique
Dans International Journal of Drug Policy (Vol.119, September 2023) Article : Périodique
The World Health Organization's list of cost-effective alcohol control policies is a widely-used resource that highlights strategies to address alcohol-related harms. However, there is more evidence on how recommended policies impact harms to pe[...]
Historique